WIM
TFFP

Westside Investment Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Westside Investment Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-75,264
Closed -$151K – 1026
2024
Q3 		$151K Buy
75,264
+24,773
+49% +$48.8K 0.03% 261
2024
Q2 		$83.8K Buy
50,491
+11,266
+29% +$29.6K 0.02% 320
2024
Q1 		$237K Buy
39,225
+31,089
+382% +$203K 0.06% 210
2023
Q4 		$57.1K Buy
8,136
+6,392
+367% +$49.7K 0.01% 341
2023
Q3 		$15.3K Sell
1,744
-41
-2% -$384 ﹤0.01% 521
2023
Q2 		$21K Sell
1,785
-4
-0.2% -$57 0.01% 487
2023
Q1 		$30.7K Sell
1,789
-240
-12% -$5.2K 0.01% 433
2022
Q4 		$53 Sell
2,029
-50
-2% -$2.37K ﹤0.01% 411
2022
Q3 		$211 Buy
2,079
+13
+0.6% +$1.76K ﹤0.01% 319
2022
Q2 		$291 Buy
2,066
+218
+12% +$30.4K ﹤0.01% 305
2022
Q1 		$291 Buy
1,848
+1,057
+134% +$171K ﹤0.01% 310
2021
Q4 		$175 Buy
+791
New +$153K ﹤0.01% 315

Other funds holding TFFP

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Westside Investment Management's TFFP Position: Q4 2024 in Review

Westside Investment Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 75,264 shares — an estimated $151K sold.

Westside Investment Management first reported a position in TFFP in Q4 2021 and held it in 12 quarters. The position peaked at $237K in Q1 2024. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.

  • Westside Investment Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Westside Investment Management sold 75,264 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $151K.
  • Westside Investment Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • Westside Investment Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $237K in Q1 2024.
  • 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Westside Investment Management's 13F filing for Q4 2024, filed 17 Jan 2025.